SCHEMBL5887667

SCHEMBL5887667

COC1=CC[CH]C(c2ccccc2C)=C1c1ccc(Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSP90AA1 P07900 2/20 0.35
HSP90AB1 P08238 2/20 0.35
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
FFAR2 O15552 2/20 0.32
CNR1 P21554 1/20 0.32
HTR7 P34969 1/20 0.31
NR1H4 Q96RI1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5887347 0.89 MEN1 (0.35) MEN1KMT2ATP53MAPTNR1H4
SCHEMBL5887625 0.88 HSP90AA1 (0.36) NPC1RAB9ATSHRHSD17B10MEN1
SCHEMBL5887653 0.87 FFAR2 (0.40) NPC1KMT2ASMN1; SMN2HSP90AA1HSP90AB1
SCHEMBL5887589 0.86 APEX1 (0.36) NPC1RAB9ASMN1; SMN2HSP90AA1HSP90AB1
SCHEMBL6416879 0.83 HPGD (0.32) HPGDMEN1KMT2AHSP90AA1HSP90AB1
SCHEMBL5887426 0.82 MEN1 (0.34) NPC1RAB9AHPGDTSHRHSD17B10
SCHEMBL5887199 0.81 KMT2A (0.35) NPC1RAB9AHPGDMEN1KMT2A
SCHEMBL5887155 0.80 NOTUM (0.36) NPC1TSHRSMN1; SMN2MAPTSLC6A3
SCHEMBL6047579 0.78 GRIA1 (0.31)
SCHEMBL5887288 0.78 ALDH1A3 (0.41) SMN1; SMN2CNR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 US claimed
JP-2006501194-A 2006-01-12 JP claimed
EP-1525190-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-04-27 EP claimed
WO-2004007463-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-01-22 WO claimed